| Net income | 8M |
| Depreciation and amortization | 18.9M |
| (Gain) loss on sale and abandonment of assets | -300K |
| Amortization of debt issuance costs | 400K |
| Non-cash stock-based compensation | 2.1M |
| Excess tax benefit related to stock option exercises | |
| Provisions (reversal) for losses on accounts receivable | 100K |
| Deferred income taxes | |
| Change in operating assets and liabilities | |
| Net cash provided by operating activities | |
| Purchase of leasehold improvements and equipment | -8.6M |
| Cost of contracts purchased | -400K |
| Proceeds from sale of assets | 2.9M |
| Capitalized interest | |
| Contingent purchase payments | |
| Net cash used in investing activities | |
| Proceeds from exercise of stock options | |
| Repurchase of common stock | -600K |
| Tax benefit related to stock option exercises | |
| Payments on senior credit facility | |
| Distribution to noncontrolling interest | -2M |
| Payments on long-term borrowings | -200K |
| Payments on capital leases | |
| Net cash used in financing activities | |
| Effect of exchange rate changes on cash and cash equivalents | |
| Increase in cash and cash equivalents | |
| Cash and cash equivalents at beginning of period | 18.7M |
| Cash and cash equivalents at end of period | 22.1M |
| Interest | 4.7M |
| Income taxes | 4.7M |